The U.S. FDA recently approved the first at-home maintenance treatment option for Alzheimer’s disease, an injectable version of the anti-amyloid Alzheimer’s treatment, Leqembi® (lecanemab). The self-injecting pen, sold as Leqembi® Iqlik™ (pronounced …